Sindrome di Beckwith-Wiedemann
Revisione paritaria di Dr Adrian Bonsall, MBBSUltimo aggiornamento di Dr Colin Tidy, MRCGPUltimo aggiornamento 11 Nov 2014
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
Avviso sui contenuti
Questa pagina non è stata aggiornata di recente, quindi alcune informazioni o alcuni link esterni potrebbero essere cambiati.
Professionisti Medici
Gli articoli di riferimento professionale sono progettati per essere utilizzati dai professionisti della salute. Sono scritti da medici del Regno Unito e basati su prove di ricerca, linee guida del Regno Unito ed europee. Potresti trovare uno dei nostri articoli sulla salute più utile.
Definizione
Beckwith-Wiedemann syndrome (BWS) is a disorder of growth regulation exhibiting somatic overgrowth and a predisposition to embryonal tumours.1Le caratteristiche includono:
Macroglossia
Abdominal wall defects
Visceromegaly
It was first described in 1964 by Dr H R Wiedemann, a geneticist from Kiel in Germany. Dr J Bruce Beckwith, a paediatric pathologist working in California, also described it in 1969. The severity of effect on the child is highly variable, with the majority minimally affected.
Patogenesi
The underlying cause is unclear. 80% of cases have genotypic abnormalities on the distal portion of chromosome 11p. The reported pattern of inheritance is autosomal dominance with variable expression. There is contiguous gene duplication at band 11p.15.5.2 This is always derived from the patient's father, whereas translocation and inversion are invariably derived from the mother. There appears to be aberrant genomic imprinting resulting from a defective or absent copy of the maternally derived gene - uniparental disomy.
Most sporadic cases lack apparent cytogenetic abnormalities. Only 2% carry inversions, translocations or deletions. 20% of sporadic cases have uniparental disomy.3 50% have loss of methylation.
Most patients with BWS show biallelic expression of insulin-like growth factor 2 (IGF2) in various tissues - see under 'Presentation', below.
Epidemiologia
Incidenza
The incidence is estimated to be 1 in 13,700. Subfertility and assisted reproduction are associated with an increased frequency of BWS.1
Recent work has suggested an association between genetic imprinting disorders (such as BWS and Angelman's syndrome) and children conceived with assisted reproduction techniques (ARTs) such as in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI).45
Presentazione
Increasingly commonly diagnosed at prenatal ultrasound.6 Suspicious features include:
Increased abdominal circumference.
Large kidneys.
Large placenta, raised amniotic fluid volume.
Protruding tongue.
Large-for-gestational-age fetus.
Raised alpha-fetoprotein with omphalocele.
Sintomi
Ipoglicemia.
Scarsa alimentazione.
Lethargy.
Problems with breathing, eating and speech, relating to the severity of macroglossia.
Segni
Crescita
Large for gestational age; the overgrowth in BWS is often the result of increased IGF2 action in the tissues. Birth weight and length are increased. Hemihypertrophy can be seen, where one part of the body, or usually all or part of one side of the body, is enlarged. This often becomes apparent in later childhood.
Accelerated growth (on 90th centile or above).
Abdominal wall defects:
Omphalocele and umbilical hernia.7
Diastasis recti causing a 'pot-belly' appearance.
Visceromegaly:
Enlarged liver, kidneys, pancreas and spleen are found.
Facial abnormalities:
Large, prominent eyes.
Creases in earlobes and pit behind the upper ear.
Pinna abnormalities, low-set ears.
Raised fontanelle, prominent occiput.
Metopic ridge, prominent on forehead due to early closure of fontanelle.
Altri:
Convulsioni.
Cryptorchidism.
Early bone maturation.
Naevus flammeus - stork bite mark over eyelids and forehead.
Renal structural anomalies, nephrocalcinosis.
Diagnosi differenziale
Fetal overgrowth syndromes - eg, Simpson-Golabi-Behmel syndrome, Perlman syndrome, Costello syndrome.
Hyperinsulinaemia.
Hyperpituitarism.
Nesidioblastosis.
Indagini
X-ray long bones.
Blood sugar testing.
X-ray, ultrasound, CT/MRI scan of abdomen.
Chromosome analysis.
Malattie associate
There is an increased risk of tumour development in children with BWS:
The incidence of malignant tumours in reported cases is 5-10%.
The most common of these is Wilms' nephroblastoma. This occurs in 5-7%. Others are hepatoblastoma and adrenal tumours. Neuroblastomi are less common.
The risk of cancer is age-dependent with most occurring by age 4 years. 95% have occurred by the age of 8 years.
Gestione
Misure generali
Screening for tumours:1
The child should have alpha-fetoprotein levels (marker for hepatoblastoma) monitored until 4 years old.
Repeated abdominal ultrasound scans until 8 years old.
Hypoglycaemia:
Screening for hypoglycaemia should be undertaken in the first few days of life.1
Hypoglycaemia should be rigorously avoided and treated, when necessary.
Diazoxide can be used to inhibit insulin secretion.
Chirurgico
If the tongue protrudes and interferes with speech and dental development, the child should be considered for reduction surgery before 4 years old.
Abdominal wall defects will need early neonatal repair. Testes may need bringing down within the scrotum.
Complicazioni
Most can be anticipated and managed:
Predisposition to embryonal malignancies:1
Most of the tumours associated with BWS occur in the first 8-10 years of life.
The most common tumours are Wilms' tumour and hepatoblastoma. Other embryonal tumours include rhabdomyosarcoma, adrenocortical carcinoma and neuroblastoma.
The overall risk for tumour development in children with BWS has been estimated at 7.5% with a range of risk estimates between 4% and 21%.
Clinical indicators of higher risks of tumour development include hemihyperplasia, nephromegaly, and nephrogenic rests.
Premature delivery.
Monozygotic twinning (usually female and discordant).
Neonatal hypoglycaemia; uncontrolled hypoglycaemia in infancy is thought to be the major aetiological factor in the reported low IQ in BWS, rather than congenital malformation.
Prognosi
The prognosis is very variable but the severe end of the spectrum may involve intrauterine, neonatal or childhood death. Death may be due to complications arising from hypoglycaemia, prematurity, cardiomyopathy, macroglossia or tumours. In contract, mildly affected children often have only subtle problems, which do not affect their quality of life.1
Aggiornamenti esclusivi per i professionisti sanitari
Rimani informato con gli ultimi aggiornamenti clinici, approfondimenti professionali e linee guida basate su evidenze. La newsletter Patient Pro seleziona contenuti essenziali per i professionisti sanitari—consegnati direttamente nella tua casella di posta.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.
Ulteriori letture e riferimenti
- Weksberg R, Shuman C, Beckwith JB; Beckwith-Wiedemann syndrome. Eur J Hum Genet. 2010 Jan;18(1):8-14. doi: 10.1038/ejhg.2009.106. Epub .
- Beckwith-Wiedemann Syndrome, BWS; Ereditarietà Mendeliana Online nell'Uomo (OMIM)
- Bestor TH; Imprinting errors and developmental asymmetry. Philos Trans R Soc Lond B Biol Sci. 2003 Aug 29;358(1436):1411-5.
- Gosden R, Trasler J, Lucifero D, et al; Rare congenital disorders, imprinted genes, and assisted reproductive technology. Lancet. 2003 Jun 7;361(9373):1975-7.
- Klemetti R, Gissler M, Sevon T, et al; Children born after assisted fertilization have an increased rate of major congenital anomalies. Fertil Steril. 2005 Nov;84(5):1300-7.
- Williams DH, Gauthier DW, Maizels M; Prenatal diagnosis of Beckwith-Wiedemann syndrome. Prenat Diagn. 2005 Oct;25(10):879-84.
- Grati FR, Turolla L, D'Ajello P, et al; Chromosome 11 segmental paternal isodisomy in amniocytes from two fetuses with omphalocoele: new highlights on phenotype-genotype correlations in Beckwith-Wiedemann syndrome. J Med Genet. 2007 Apr;44(4):257-63. Epub 2007 Jan 26.
Informazioni sul recensoreVisualizza il profilo completo

Dott. Adrian Bonsall, MBBS
Autore Medico
MA (Chimica), MBBS (Hons), DCH
Dal 2000 Adrian lavora in pediatria d'emergenza e terapia intensiva a Sydney, con particolari interessi in tossicologia, traumi e rianimazione.
Di più sui disturbi congeniti ed ereditari
- Sindrome di Angelman
- Atassia con teleangiectasia
- Sindrome linfoproliferativa autoimmune
- Deficienza di biotinidasi
- Disturbi emorragici
- Sindrome di Chediak-Higashi
- Cisti del coledoco
- Deficienze del complemento
- Ernia diaframmatica congenita
- Cardiopatia congenita negli adulti
- Cardiopatia congenita nei bambini
- Sindrome di Edwards
- sindromi di Ehlers-Danlos
- Fibroelastosi endocardica
- Emofilia B
- Immunodeficienza
- Neuropatia ottica ereditaria di Leber
- Nanoismo di Mulibrey
- Anemia perniciosa e carenza di B12
- Xeroderma pigmentoso


